Table of Contents
Bone Marrow Research
Volume 2014, Article ID 541345, 9 pages
http://dx.doi.org/10.1155/2014/541345
Research Article

Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity

1Laboratory of Immunogenetics, Department of Transfusion Medicine, Cell Therapeutic Agents and Hemostaseology, University Hospital of Munich, Ludwig Maximilians University, Max-Lebsche-Platz 32, 81377 Munich, Germany
2Department of Internal Medicine III, University Hospital of Munich, Ludwig Maximilians University, Max-Lebsche-Platz 32, 81377 Munich, Germany

Received 27 November 2013; Revised 21 February 2014; Accepted 28 February 2014; Published 3 April 2014

Academic Editor: Peter J. Quesenberry

Copyright © 2014 Klaus Witter et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. L. Amir, D. M. van der Steen, M. M. van Loenen et al., “PRAME-specific allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transfer,” Clinical Cancer Research, vol. 17, no. 17, pp. 5615–5625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. X.-Y. Zhao, Y.-J. Chang, and X.-J. Huang, “Conflicting impact of alloreactive NK cells on transplantation outcomes after HLA haploidentical transplantation: do the reconstitution kinetics of natural killer cells create these differences?” Biology of Blood and Marrow Transplantation, vol. 17, no. 10, pp. 1436–1442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Asai, Y. Liu, N. Bae, and S. D. Nimer, “The p53 tumor suppressor protein regulates hematopoietic stem cell fate,” Journal of Cellular Physiology, vol. 226, no. 9, pp. 2215–2221, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. O'Keefe, M. A. McDevitt, and J. P. Maciejewski, “Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies,” Blood, vol. 115, no. 14, pp. 2731–2739, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Vago, S. K. Perna, M. Zanussi et al., “Loss of mismatched HLA in leukemia after stem-cell transplantation,” The New England Journal of Medicine, vol. 361, no. 5, pp. 478–488, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Coppage, A. Iqbal, A. Ahmad, and M. W. Becker, “Leukemia specific loss of heterozygosity of MHC in a CLL patient: disease state impacts timing of confirmatory typing,” Human Immunology, vol. 74, no. 1, pp. 41–44, 2013. View at Google Scholar
  7. V. Dubois, F. Sloan-Béna, A. Cesbron et al., “Pretransplant HLA mistyping in diagnostic samples of acute myeloid leukemia patients due to acquired uniparental disomy,” Leukemia, vol. 26, no. 9, pp. 2079–2085, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Ikegame, K. Kaida, L. Lakoma et al., “HLA haploidentical hematopoietic stem cell transplantation for lymphoma with monosomy of chromosome 6 (loss of heterozygosity in the HLA region)—who should be a donor?” Transplant Immunology, vol. 27, no. 4, pp. 162–165, 2012. View at Google Scholar
  9. I. Niebele, B. Grumbt, K. Witter et al., “HLA haplotype deletion in leukemic cells may affect HLA typing and must be considered in donor selection,” Tissue Antigens, vol. 77, no. 5, p. 417, 2011. View at Google Scholar
  10. A. G. Smith, W. Fan, L. Regen et al., “Somatic mutations in the HLA genes of patients with hematological malignancy,” Tissue Antigens, vol. 79, no. 5, pp. 359–366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. J. A. L. Armour, D. E. Barton, D. J. Cockburn, and G. R. Taylor, “The detection of large deletions or duplications in genomic DNA,” Human Mutation, vol. 20, no. 5, pp. 325–337, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. F. B. L. Hogervorst, P. M. Nederlof, J. J. P. Gille et al., “Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method,” Cancer Research, vol. 63, no. 7, pp. 1449–1453, 2003. View at Google Scholar · View at Scopus
  13. W. Kern, S. Danhauser-Riedl, R. Ratei et al., “Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry to define leukemia-associated immunophenotypes and determine their frequencies in normal bone marrow,” Haematologica, vol. 88, no. 6, pp. 646–653, 2003. View at Google Scholar · View at Scopus
  14. K. Witter, E. Keller, M. Kutsch, T. Albert, and A. Dick, “HLA-DQB1*06:41 shown by sequence-based typing may be associated with DRB1*13:02,” Tissue Antigens, vol. 78, no. 3, pp. 223–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Witter, M. Kutsch, R. Zahn, A. Volgger, and A. Dick, “Sequence-based typing confirmed a new HLA-A allele, A*68:71,” Tissue Antigens, vol. 78, no. 1, pp. 69–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Gorczyca, Z.-Y. Sun, W. Cronin, X. Li, S. Mau, and S. Tugulea, “Immunophenotypic pattern of myeloid populations by flow cytometry analysis,” Methods in Cell Biology, vol. 103, pp. 221–266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C.-W. Pyo, L. M. Williams, Y. Moore et al., “HLA-E, HLA-F, and HLA-G polymorphism: genomic sequence defines haplotype structure and variation spanning the nonclassical class I genes,” Immunogenetics, vol. 58, no. 4, pp. 241–251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Waterhouse, D. Pfeifer, M. Pantic, F. Emmerich, H. Bertz, and J. Finke, “Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation,” Biology of Blood and Marrow Transplantation, vol. 17, no. 10, pp. 1450–1459, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Ding, T. J. Ley, D. E. Larson et al., “Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing,” Nature, vol. 481, no. 7382, pp. 506–510, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Baron and B. M. Sandmaier, “Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning,” Leukemia, vol. 20, no. 10, pp. 1690–1700, 2006. View at Publisher · View at Google Scholar · View at Scopus